18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
The differential diagnosis of primary central nervous system lymphoma from glioblastoma multiforme (GBM) is essential due to the difference in treatment strategies. This study retrospectively reviewed 77 patients (24 with lymphoma and 53 with GBM) to identify the stable and distinguishable character...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | NeuroImage: Clinical |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158219302621 |
id |
doaj-e56bf7a0ea4742a28ee33ca9e559927a |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ziren Kong Chendan Jiang Ruizhe Zhu Shi Feng Yaning Wang Jiatong Li Wenlin Chen Penghao Liu Dachun Zhao Wenbin Ma Yu Wang Xin Cheng |
spellingShingle |
Ziren Kong Chendan Jiang Ruizhe Zhu Shi Feng Yaning Wang Jiatong Li Wenlin Chen Penghao Liu Dachun Zhao Wenbin Ma Yu Wang Xin Cheng 18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma NeuroImage: Clinical |
author_facet |
Ziren Kong Chendan Jiang Ruizhe Zhu Shi Feng Yaning Wang Jiatong Li Wenlin Chen Penghao Liu Dachun Zhao Wenbin Ma Yu Wang Xin Cheng |
author_sort |
Ziren Kong |
title |
18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma |
title_short |
18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma |
title_full |
18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma |
title_fullStr |
18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma |
title_full_unstemmed |
18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma |
title_sort |
18f-fdg-pet-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma |
publisher |
Elsevier |
series |
NeuroImage: Clinical |
issn |
2213-1582 |
publishDate |
2019-01-01 |
description |
The differential diagnosis of primary central nervous system lymphoma from glioblastoma multiforme (GBM) is essential due to the difference in treatment strategies. This study retrospectively reviewed 77 patients (24 with lymphoma and 53 with GBM) to identify the stable and distinguishable characteristics of lymphoma and GBM in 18F-fluorodeocxyglucose (FDG) positron emission tomography (PET) images using a radiomics approach. Three groups of maps, namely, a standardized uptake value (SUV) map, an SUV map calibrated with the normal contralateral cortex (ncc) activity (SUV/ncc map), and an SUV map calibrated with the normal brain mean (nbm) activity (SUV/nbm map), were generated, and a total of 107 radiomics features were extracted from each SUV map. The margins of the ROI were adjusted to assess the stability of the features, and the area under the curve (AUC) of the receiver operating characteristic curve of each feature was compared with the SUVmax to evaluate the distinguishability of the features. Nighty-five radiomics features from the SUV map were significantly different between lymphoma and GBM, 46 features were numeric stable after marginal adjustment, and 31 features displayed better performance than SUVmax. Features extracted from the SUV map demonstrated higher AUCs than features from the further calibrated maps. Tumors with solid metabolic patterns were also separately evaluated and revealed similar results. Thirteen radiomics features that were stable and distinguishable than SUVmax in every circumstance were selected to distinguish lymphoma from glioblastoma, and they suggested that lymphoma has a higher SUV in most interval segments and is more mathematically heterogeneous than GBM. This study suggested that 18F-FDG-PET-based radiomics is a reliable noninvasive method to distinguish lymphoma and GBM. Keywords: 18F-FDG, Positron emission tomography, Glioblastoma, Lymphoma, Radiomics |
url |
http://www.sciencedirect.com/science/article/pii/S2213158219302621 |
work_keys_str_mv |
AT zirenkong 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT chendanjiang 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT ruizhezhu 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT shifeng 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT yaningwang 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT jiatongli 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT wenlinchen 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT penghaoliu 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT dachunzhao 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT wenbinma 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT yuwang 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma AT xincheng 18ffdgpetbasedradiomicsfeaturestodistinguishprimarycentralnervoussystemlymphomafromglioblastoma |
_version_ |
1724960528894263296 |
spelling |
doaj-e56bf7a0ea4742a28ee33ca9e559927a2020-11-25T02:00:26ZengElsevierNeuroImage: Clinical2213-15822019-01-012318F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastomaZiren Kong0Chendan Jiang1Ruizhe Zhu2Shi Feng3Yaning Wang4Jiatong Li5Wenlin Chen6Penghao Liu7Dachun Zhao8Wenbin Ma9Yu Wang10Xin Cheng11Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, China; School of Medicine, Tsinghua University, Haidian District, Beijing, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, China; Corresponding authors.The differential diagnosis of primary central nervous system lymphoma from glioblastoma multiforme (GBM) is essential due to the difference in treatment strategies. This study retrospectively reviewed 77 patients (24 with lymphoma and 53 with GBM) to identify the stable and distinguishable characteristics of lymphoma and GBM in 18F-fluorodeocxyglucose (FDG) positron emission tomography (PET) images using a radiomics approach. Three groups of maps, namely, a standardized uptake value (SUV) map, an SUV map calibrated with the normal contralateral cortex (ncc) activity (SUV/ncc map), and an SUV map calibrated with the normal brain mean (nbm) activity (SUV/nbm map), were generated, and a total of 107 radiomics features were extracted from each SUV map. The margins of the ROI were adjusted to assess the stability of the features, and the area under the curve (AUC) of the receiver operating characteristic curve of each feature was compared with the SUVmax to evaluate the distinguishability of the features. Nighty-five radiomics features from the SUV map were significantly different between lymphoma and GBM, 46 features were numeric stable after marginal adjustment, and 31 features displayed better performance than SUVmax. Features extracted from the SUV map demonstrated higher AUCs than features from the further calibrated maps. Tumors with solid metabolic patterns were also separately evaluated and revealed similar results. Thirteen radiomics features that were stable and distinguishable than SUVmax in every circumstance were selected to distinguish lymphoma from glioblastoma, and they suggested that lymphoma has a higher SUV in most interval segments and is more mathematically heterogeneous than GBM. This study suggested that 18F-FDG-PET-based radiomics is a reliable noninvasive method to distinguish lymphoma and GBM. Keywords: 18F-FDG, Positron emission tomography, Glioblastoma, Lymphoma, Radiomicshttp://www.sciencedirect.com/science/article/pii/S2213158219302621 |